Biopol Chemicals Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹2(1.85%)
Premium (ELP)
Biopol Chemicals Limited's achieved publicly listed status following its IPO debut on Feb 13, 2026 at the NSE platform. The offering successfully mobilized 28,94,400 Shares, with 28,94,400 Shares allocated to corporate growth initiatives.
Investment participation occurred within the established price band of ₹102 to ₹108, starting from minimum lots of 1200 shares. The subscription window from Feb 06, 2026 through Feb 10, 2026 enabled investor participation across market segments.
Share allocation was completed on Feb 11, 2026, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2023, Biopol Chemicals Limited manufactures and supplies specialty chemicals such as silicones, emulsifiers, biochemicals, and polyelectrolytes, with a total product range of 66 items used across industries like textiles, home care, agriculture, and industrial chemicals. The company follows a B2B model and serves institutional clients only. It operates four establishments located in Gujarat and West Bengal, including a manufacturing unit, corporate office, and warehouse in West Bengal, along with a registered office in Gujarat, with a total installed manufacturing capacity of 18,25,000 litres per year. As of December 31, 2025, the company had a workforce of 24 employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Diversified specialty product portfolio: The company offers 66 products across silicones, emulsifiers, biochemicals, and polyelectrolytes, serving multiple industries and reducing dependence on any single sector.
- B2B-focused business model: The company caters to institutional clients, which supports bulk orders, long-term relationships, and relatively stable demand compared to retail-focused chemical businesses.
- Adequate manufacturing capacity with strategic locations: With an installed capacity of 18,25,000 litres per annum and facilities in Gujarat and West Bengal, the company ensures efficient production and wider regional market reach.
- Limited operating history: Incorporated in 2023, the company has a short track record, which may affect customer confidence and long-term business visibility.
- Small workforce size: With only 24 employees as of December 31, 2025, the company may face challenges in scaling operations and strengthening R&D as it grows.
- Customer concentration risk: A B2B model focused on institutional clients may lead to revenue fluctuations if key customers reduce orders or shift to other suppliers.
- Mr. Santanu Sarkar
- Mr. Vedant Sarkar
Biopol Chemicals Limited
Bigshare Services Private Limited